Aurora Cannabis Inc. (ACB) vs Fulcrum Therapeutics, Inc. (FULC)
A side-by-side comparison of Aurora Cannabis Inc. and Fulcrum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACB
Aurora Cannabis Inc.
$4.52HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
FULC
Fulcrum Therapeutics, Inc.
$3.70HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — ACB vs FULC
growth of $100 · dividends reinvested · last 7yACB -99.5% (-52.7%/yr)FULC -72.5% (-16.8%/yr)FULC compounded faster over this window
Log scale — wide-divergence pair
ACB FULC
ACB vs FULC: by the numbers
- •FULC is the larger company ($282M vs $280M market cap).
- •Both run net losses; FULC's is the smaller (0.00% vs -38.13% net margin).
Metrics side by side
Valuation
| Metric | ACB | FULC |
|---|---|---|
| P/S ratio | 1.34 | N/A |
| P/B ratio | 0.75 | 0.91 |
Profitability
| Metric | ACB | FULC |
|---|---|---|
| Gross margin | 42.62% | 0.00% |
| Operating margin | -14.55% | 0.00% |
| Net margin | -38.13% | 0.00% |
| ROE | -21.41% | -27.36% |
| ROIC | -15.69% | -27.62% |
Growth (annualized)
| Metric | ACB | FULC |
|---|---|---|
| Revenue CAGR (5Y) | 1.68% | N/A |
| Total return CAGR (5Y) | -42.83% | -31.70% |
Frequently asked
- How have ACB and FULC total returns compared?
- Over the past 5 years, ACB delivered -42.83% and FULC delivered -31.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.